Revenue Summary of Roche Holding AG

Roche Holding AG's latest annual revenue in 2023 was 60.44 Billion CHF , down -4.49% from previous year.
Roche Holding AG's latest quarterly revenue in 2024 Q2 was 15.37 Billion CHF , down 0.0% from previous quarter.
Roche Holding AG reported a annual revenue of 63.28 Billion CHF in annual revenue 2022, up 0.76% from previous year.
Roche Holding AG reported a annual revenue of 62.8 Billion CHF in annual revenue 2021, up 7.68% from previous year.
Roche Holding AG reported a quarterly revenue of 15.37 Billion CHF for 2024 Q1, down -46.86% from previous quarter.
Roche Holding AG reported a quarterly revenue of 60.44 Billion CHF for 2023 FY, down -4.49% from previous quarter.

Annual Revenue Chart of Roche Holding AG (2023 - 1998)

Historical Annual Revenue of Roche Holding AG (2023 - 1998)

Year	Revenue	Revenue Growth
2023	60.44 Billion CHF	-4.49%
2022	63.28 Billion CHF	0.76%
2021	62.8 Billion CHF	7.68%
2020	58.32 Billion CHF	-5.11%
2019	61.46 Billion CHF	8.13%
2018	56.84 Billion CHF	6.65%
2017	53.29 Billion CHF	5.38%
2016	50.57 Billion CHF	5.05%
2015	48.14 Billion CHF	1.44%
2014	47.46 Billion CHF	1.46%
2013	46.78 Billion CHF	2.82%
2012	45.49 Billion CHF	6.98%
2011	42.53 Billion CHF	-10.41%
2010	47.47 Billion CHF	-3.22%
2009	49.05 Billion CHF	7.53%
2008	45.61 Billion CHF	-1.12%
2007	46.13 Billion CHF	9.73%
2006	42.04 Billion CHF	18.39%
2005	35.51 Billion CHF	13.55%
2004	31.27 Billion CHF	0.17%
2003	31.22 Billion CHF	5.03%
2002	29.72 Billion CHF	1.93%
2001	29.16 Billion CHF	1.71%
2000	28.67 Billion CHF	4.01%
1999	27.56 Billion CHF	11.78%
1998	24.66 Billion CHF	0.0%

Year	Revenue	Revenue Growth
2024 Q2	15.37 Billion CHF	0.0%
2024 Q1	15.37 Billion CHF	-46.86%
2023 FY	60.44 Billion CHF	-4.49%
2023 Q3	14.91 Billion CHF	-49.92%
2023 Q4	28.93 Billion CHF	94.05%
2023 Q2	29.77 Billion CHF	94.53%
2023 Q1	15.3 Billion CHF	-50.6%
2022 FY	63.28 Billion CHF	0.76%
2022 Q4	30.98 Billion CHF	94.18%
2022 Q1	16.95 Billion CHF	-47.18%
2022 Q2	32.29 Billion CHF	90.53%
2022 Q3	15.95 Billion CHF	-50.59%
2021 Q1	16.06 Billion CHF	-44.68%
2021 FY	62.8 Billion CHF	7.68%
2021 Q3	16.85 Billion CHF	-45.11%
2021 Q4	32.08 Billion CHF	90.34%
2021 Q2	30.71 Billion CHF	91.16%
2020 FY	58.32 Billion CHF	-5.11%
2020 Q1	15.18 Billion CHF	-51.0%
2020 Q2	29.28 Billion CHF	92.78%
2020 Q3	14.98 Billion CHF	-48.83%
2020 Q4	29.04 Billion CHF	93.84%
2019 Q4	30.99 Billion CHF	93.73%
2019 Q1	15.87 Billion CHF	5.94%
2019 Q2	15.87 Billion CHF	0.0%
2019 FY	61.46 Billion CHF	8.13%
2019 Q3	16 Billion CHF	0.78%
2018 Q1	14.76 Billion CHF	4.71%
2018 FY	56.84 Billion CHF	6.65%
2018 Q4	14.98 Billion CHF	0.0%
2018 Q3	14.98 Billion CHF	1.5%
2018 Q2	14.76 Billion CHF	0.0%
2017 Q2	13.77 Billion CHF	0.0%
2017 Q1	13.77 Billion CHF	3.46%
2017 FY	53.29 Billion CHF	5.38%
2017 Q4	14.09 Billion CHF	0.0%
2017 Q3	14.09 Billion CHF	2.36%
2016 Q1	13 Billion CHF	1.7%
2016 FY	50.57 Billion CHF	5.05%
2016 Q2	13 Billion CHF	0.0%
2016 Q4	13.31 Billion CHF	0.0%
2016 Q3	13.31 Billion CHF	2.38%
2015 FY	48.14 Billion CHF	1.44%
2015 Q1	12.41 Billion CHF	-2.6%
2015 Q4	12.78 Billion CHF	0.0%
2015 Q3	12.78 Billion CHF	2.99%
2015 Q2	12.41 Billion CHF	0.0%
2014 Q3	12.74 Billion CHF	4.6%
2014 FY	47.46 Billion CHF	1.46%
2014 Q4	12.74 Billion CHF	0.0%
2014 Q2	12.18 Billion CHF	0.0%
2014 Q1	12.18 Billion CHF	0.05%
2013 FY	46.78 Billion CHF	2.82%
2013 Q2	12.12 Billion CHF	0.0%
2013 Q3	12.18 Billion CHF	0.45%
2013 Q4	12.18 Billion CHF	0.0%
2013 Q1	12.12 Billion CHF	0.0%
2012 FY	45.49 Billion CHF	6.98%
2011 FY	42.53 Billion CHF	-10.41%
2010 FY	47.47 Billion CHF	-3.22%
2009 FY	49.05 Billion CHF	7.53%
2008 FY	45.61 Billion CHF	-1.12%
2007 FY	46.13 Billion CHF	9.73%
2006 FY	42.04 Billion CHF	18.39%
2005 FY	35.51 Billion CHF	13.55%
2004 FY	31.27 Billion CHF	0.17%
2003 FY	31.22 Billion CHF	5.03%
2002 FY	29.72 Billion CHF	1.93%
2001 FY	29.16 Billion CHF	1.71%
2000 FY	28.67 Billion CHF	4.01%
1999 FY	27.56 Billion CHF	11.78%
1998 FY	24.66 Billion CHF	0.0%

Peer Revenue Comparison of Roche Holding AG

Name	Revenue	Revenue Difference
AstraZeneca PLC	46.91 Billion USD	-28.832%
Bristol-Myers Squibb Company PFD CONV 2	45 Billion USD	-34.295%
CSPC Pharmaceutical Group Limited	31.45 Billion USD	-92.181%
Clarus Therapeutics Holdings, Inc.	13.95 Million USD	-432951.515%
Novartis AG	46.66 Billion USD	-29.535%
PT Kalbe Farma Tbk.	1.97 Billion USD	-2953.819%

Global Stocks Search

Roche Holding AG (RHHBF)

Revenue Summary of Roche Holding AG

Annual Revenue Chart of Roche Holding AG (2023 - 1998)

Historical Annual Revenue of Roche Holding AG (2023 - 1998)

Peer Revenue Comparison of Roche Holding AG